1. Home
  2. CMND

CMND

Clearmind Medicine Inc.

Logo Clearmind Medicine Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 10:32am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Founded: 2017 Country:
Canada
Canada
Employees: 4 City: N/A
Market Cap: 3.9M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 778.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -22.60 EPS Growth: N/A
52 Week Low/High: $0.92 - $24.66 Next Earning Date: 05-05-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: